Skip to main content

Table 3 Metabolic Syndrome criteria and Insulin Resistance

From: Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study

 

Age 3–8

Age 9–11

Age 12–19

 

Higher IR

Higher IR

Higher IR

MetS Criterion*

Yes

No

Yes

No

Yes

No

 

n = 41

n = 81

n = 54

n = 110

n = 96

n = 194

Waist Circumference %

95

94 (p > .99)

100.

93 (p = .05)

94

82 (p = .01)

Blood Pressure %

66

64 (p > .99)

56

53 (p = .86)

65

56 (p = .21)

Glucose %

7

0 (p = .04)

11

1 (p = .01)

9

1 (p < .01)

Triglycerides %

37

33 (p = .88)

48

46 (p = .96)

41

23 (p < .01)

HDL %

44

37 (p = .59)

48

45 (p = .79)

56

47 (p = .17)

 

Age 3–8

Age 9–11

Age 12–19

Number of Components ‡

 

Higher IR †

 

Higher IR

 

Higher IR

 

n

% (n)

n

% (n)

n

% (n)

None

3

0 (0)

1

0 (0)

12

8 (1)

Any one

21

29 (6)

32

22 (7)

67

24 (16)

Any two

43

35 (15)

52

35 (18)

88

31 (27)

Any three

40

35 (14)

51

37 (19)

80

35 (28)

Any four

15

40 (6)

26

31 (8)

38

53 (20)

All five

0

-

2

100 (2)

5

80 (4)

  1. * Metabolic syndrome (MetS) by modified ATP III criteria: any 3 or more of waist circumference, blood pressure and triglycerides ≥ 90th percentile, HDL ≤ 40 mg/dL, Glucose ≥ 100 mg/dl. Higher insulin resistance (IR): upper tertile of HOMA. Values presented as %.
  2. † % of the number (n) within that age group who had insulin resistance (IR), defined as upper tertile of HOMA.
  3. ‡Test of association (Spearman's rho) of number of categories with higher IR within age group: age 3–8 (p = .34), age 9–11 (p = .18), age 12–19 (p < .01).
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840